CA-based XStream Trucking bags $10.5 million in Series A funding
Category: #business  By Mateen Dalal  Date: 2019-05-30
  • share
  • Twitter
  • Facebook
  • LinkedIn

CA-based XStream Trucking bags $10.5 million in Series A funding

The investment will be used to enhance XStream’s ability to deliver better fuel-efficiency to the U.S. trucking industry by means of innovative hardware & software solutions.

Renowned vehicle design & engineering company, XStream Trucking, Inc. has recently announced securing US$10.5 million in Series A funding co-led by Calibrate Ventures and Autotech Ventures, along with participation from the existing shareholders of Root Ventures, Uncork Capital, FusionX and Tandem Capital.

According to reliable sources, the investment will be used to accelerate XStream’s ability to deliver enhanced fuel economy to the $700 billion U.S. trucking industry by means of advanced hardware and software solutions.

For the record, XStream’s flagship technology, TruckWings, is an active-aero device that closes the tractor-trailer gap automatically on commercial trucks when the vehicle is running at a certain speed, creating an estimated fuel savings of between 4-6%. It also offers GPS-enabled software that tracks fuel savings in real-time.

As per a statement, Daniel Burrows, CEO, XStream Trucking, said that fuel represents a key expense for commercial trucking fleets and with their products large fleets could save millions each year. He stated that the firm’s branded technology and advanced processes effectively address a previously neglected area of truck aerodynamics.

He further added that XStream Trucking is thrilled to have the support of Calibrate Ventures and Autotech Ventures, which will help them expand the company’s capabilities to deliver several U.S. trucking firms with cost-saving technology & software-based insights.

Speaking on the move, Jason Schoettler, Co-Founder, Calibrate Ventures, said that the trucking industry stands as the backbone of the American economy and technologies that enhance fuel economy and performance will certainly make a considerable impact throughout the value chain.

Meanwhile, Maurice Gunderson, MD, Autotech Ventures, said that their firm is thrilled to partner with XStream Trucking and witness the impact of its investment on the commercial trucking industry. He added that the company is looking forward to collaborating with XStream Trucking to continue developing innovative offerings that leave a long-term mark on the global logistics industry.

Source Credit: https://www.globenewswire.com/news-release/2019/05/29/1856289/0/en/XStream-Trucking-Secures-10-5-Million-Series-A-Funding-Round-Led-by-Autotech-Ventures-and-Calibrate-Ventures.html

https://www.freightwaves.com/news/xstream-trucking

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Peraton to acquire innovative IT solutions provider Solers Inc.
Peraton to acquire innovative IT solutions provider Solers Inc.
By Mateen Dalal

Virginia-based Peraton, a defense and intelligence contractor owned by private equity firm Veritas Capital, reportedly announced that it has signed a definitive agreement to acquire Solers Inc., a leading provider of software development and cybersec...

Forty Seven publishes data on Phase 1b/2 clinical trial of 5F9
Forty Seven publishes data on Phase 1b/2 clinical trial of 5F9
By Mateen Dalal

A clinical-stage immune-oncology company, Forty Seven, Inc., that works to develop therapies targeting cancer immune evasion pathways, has revealed clinical data from Phase 1b/2. The company is evaluating a new drug combination of Recombinant Human A...

FDA grants orphan drug tag to NuCana’s biliary tract cancer treatment
FDA grants orphan drug tag to NuCana’s biliary tract cancer treatment
By Mateen Dalal

NuCana is on its way to open a Global Phase III study of Acelarin in combination with cisplatin for patients who are suffering from the disease in 2019 NuCana plc recently announced that it has received Orphan Drug Designation for Acelarin, an inves...